Clinical Trials in Seoul, Gangnam-gu
18 recruiting
Showing 1–18 of 18 trials
Recruiting
Phase 2
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Metastatic Non Small Cell Lung Cancer
Iovance Biotherapeutics, Inc.170 enrolled91 locationsNCT04614103
Recruiting
Phase 2
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Ovarian CancerEndometrial CancerFallopian Tube Cancer+1 more
Corcept Therapeutics270 enrolled49 locationsNCT06906341
Recruiting
Phase 2
Niraparib With beVAcizumab After Complete cytoreductioN in Patients With ovArian Cancer
Ovarian Cancer
ARCAGY/ GINECO GROUP390 enrolled88 locationsNCT05183984
Recruiting
Phase 1Phase 2
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Metastatic Solid TumorsLocally Advanced Solid Tumors
Turning Point Therapeutics, Inc.500 enrolled165 locationsNCT03093116
Recruiting
Phase 3
Salvage Moderate Hypofractionated Versus Ultrahypofractionated Radiotherapy for Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer
Prostate Cancer
Samsung Medical Center270 enrolled1 locationNCT07500701
Recruiting
Not Applicable
COPM-Based Goal Setting Strategies in the PICU
Critical IllnessPediatric Intensive Care Unit
Samsung Medical Center5 enrolled2 locationsNCT07128446
Recruiting
Phase 1Phase 2
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Non-small Cell Lung Cancer (NSCLC)KRAS, NRAS, HRAS-mutated NSCLCKRAS G12C-mutated Solid Tumors, Lung Cancer+2 more
Revolution Medicines, Inc.616 enrolled89 locationsNCT06162221
Recruiting
Phase 2
Definitive Hypofractionated Intensity-modulated Radiation Theraphy With Concurrent Chemotherapy in Cervical Cancer
Cervical Cancer
Samsung Medical Center34 enrolled1 locationNCT07439497
Recruiting
Phase 2
Clinical Trial for Safety and Effectiveness Evaluation of Tarlatamab (AMG757) With Etoposide, Carboplatin and Atezolizumab in Transformed Small Cell Lung Cancer Patients From Adenocarcinoma After EGFR TKI Treatment
Small Cell Carcinoma of Lung
Se-Hoon Lee50 enrolled1 locationNCT06830694
Recruiting
Phase 2
Lazertinib & Tepotinib for EGFR Mutant NSCLC in MET Overexpressed or Amplified Who Progressed After Lazertinib Treatment
Non-small Cell Lung Cancer Metastatic
Samsung Medical Center47 enrolled1 locationNCT06106802
Recruiting
Not Applicable
Nostril Side on Epistaxis
Nasotracheal Intubation
Seoul National University Hospital208 enrolled2 locationsNCT06605989
Recruiting
Phase 1Phase 2
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
HER2-positive Advanced Solid Tumor
DualityBio Inc.796 enrolled102 locationsNCT05150691
Recruiting
A Study to Learn About the Study Medicine Zavicefta After it is Released Into the Markets in Korea
Hospital-Acquired PneumoniaComplicated urinary tract infectionComplicated Intra-abdominal Infection
Pfizer600 enrolled1 locationNCT05733104
Recruiting
Not Applicable
Comparison of Ultrasound and Breast MRI for Breast Cancer Detection
Breast CancerBreast Neoplasms
Samsung Medical Center1,756 enrolled3 locationsNCT05797545
Recruiting
Phase 1Phase 2
A Beta-only IL-2 ImmunoTherapY Study
Triple-Negative Breast CancerEsophageal CancerGastric Cancer+34 more
Medicenna Therapeutics, Inc.115 enrolled27 locationsNCT05086692
Recruiting
Not Applicable
PETAL Trial: Impact of Gallium-68 Pentixafor PET-CT on Surgical Outcomes in Primary Aldosteronism
Primary AldosteronismSecondary HypertensionAldosterone-Producing Adenoma+2 more
Seoul National University Hospital90 enrolled2 locationsNCT07027254
Recruiting
Genomic Analysis to Identify a Predictive Biomarker for Immunotherapy
Lung Cancer
Se-Hoon Lee800 enrolled3 locationsNCT03578185
Recruiting
Phase 3
Comparison of Conventional and Hypofractionated IMRT in High-Risk Cervical Cancer Post-Radical Hysterectomy
Uterine Cervical Neoplasms
Samsung Medical Center248 enrolled1 locationNCT06509724